Interpharm Holdings, Inc. Stock

Stocks

IPAH

US4605881063

Pharmaceuticals

OTC Markets Traded
Market Closed - OTC Markets 10:25:29 2026-06-05 EDT 5-day change 1st Jan Change
0.000010 USD +900.00% Intraday chart for Interpharm Holdings, Inc. -.--% +900.00%

Valuation: Interpharm Holdings, Inc.

Market Cap 1.07M 940K 873K 802K 1.5M 103M 1.53M 10.37M 4.05M 50.54M 4.01M 3.92M 175M P/E 2006
-9.26x
P/E 2007 -4.96x
Enterprise Value 27.54M 24.23M 22.52M 20.68M 38.81M 2.66B 39.46M 267M 104M 1.3B 103M 101M 4.51B EV / Sales 2006
1.63x
EV / Sales 2007 1.47x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.01
10 years 0
Extreme 0
0.02
Change 5-day change 1-year change 3-year change Capi.($)
+900.00%-.--% - - 667
+0.86%+1.43%+48.50%+160.39% 1,067B
+1.59%+4.09%+55.34%+53.96% 635B
+0.95%+1.91%+35.91%+81.14% 458B
+1.60%+6.25%+33.95%+29.84% 347B
-0.60%+1.52%+35.68%+39.76% 295B
-0.14%+0.60%+16.17%+17.53% 262B
+0.09%-2.82%-28.29%-41.71% 216B
+1.22%+2.66%+21.87%+59.73% 203B
-1.18%-3.70%+14.23%+66.51% 161B
Average +90.44%+1.19%+25.93%+51.91% 364.3B
Weighted average by Cap. +0.76%+1.95%+35.81%+77.68%

Financials

2006 2007
Net sales 63.36M 55.75M 51.81M 47.57M 89.28M 6.12B 90.78M 615M 240M 3B 238M 233M 10.38B 75.59M 66.51M 61.81M 56.75M 107M 7.3B 108M 734M 287M 3.58B 284M 278M 12.38B
Net income -3.79M -3.33M -3.1M -2.85M -5.34M -366M -5.43M -36.81M -14.37M -179M -14.23M -13.92M -621M -14.06M -12.37M -11.5M -10.55M -19.81M -1.36B -20.14M -137M -53.31M -665M -52.77M -51.63M -2.3B
Net Debt 14.2M 12.49M 11.61M 10.66M 20.01M 1.37B 20.35M 138M 53.85M 672M 53.3M 52.16M 2.33B 26.47M 23.29M 21.65M 19.88M 37.31M 2.56B 37.93M 257M 100M 1.25B 99.37M 97.23M 4.34B
Logo Interpharm Holdings, Inc.
Interpharm Holdings, Inc., through its wholly owned subsidiary, Interpharm, Inc., is engaged in the business of developing, manufacturing and marketing generic prescription strength and over-the-counter pharmaceuticals. The Company sells its products under its own label to the major retailers, wholesalers, managed care organizations and national distributors, and under private label to wholesalers, distributors, repackagers and other manufacturers. During the fiscal year ended June 30, 2007 (fiscal 2007), the Company manufactured and marketed 36 generic pharmaceutical products, which represent various oral dosage strengths for 11 products and different dosage strengths for 25 of these products.
Employees
670
  1. Stock Market
  2. Stocks
  3. IPAH Stock